Protocol Page


	Study ID (Protocol Number)
	CN167-003


	STUDY LOCATIONS*
	Compass Research Orlando, FL 32806 Recruiting	Local Institution Anaheim, CA 92801 Not yet recruiting
	Local Institution Tucson, AZ 85724 Not yet recruiting	Local Institution Garden Grove, CA 92845 Not yet recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
	STUDY OVERVIEW
	The purpose of the study is to evaluate safety and the pharmacodynamic effects of BMS-241027 on cerebrospinal fluid (CSF) Tau, connectivity magnetic resonance imaging (MRI), and computerized cognitive tests in mild Alzheimer's disease (AD) subjects, following 9 weekly intravenous (IV) infusions of BMS-241027

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.